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Abstract
Background: Porcine circovirus type 2 (PCV2) is a dominant causative agent of postweaning
multisystemic wasting syndrome (PMWS), a multifactorial disease complex with putative
immunosuppressive characteristics. Little is known about adaptive PCV2-specific immune
responses in infected pigs. Therefore, the T and B cell responses following PCV2 infection in 3-
week old SPF piglets infected with PCV2 or PCV2 plus porcine parvovirus (PPV) were studied.
Results: All animals were asymptomatically infected. At 7 days post infection (d p.i.), B lymphocyte
and T lymphocyte numbers decreased in the dual infected, but not in the single infected piglets. At
this time point a transient PCV2 viraemia was noted in the PCV2 infected groups. Antibodies
against the infecting virus were detectable at day 24-28 p.i. for anti-PCV2 antibodies and at day 10
p.i. for anti-PPV antibodies, with no apparent influence of PCV2 on the early PPV antibody
development. In the animals infected with PPV alone, IFN-γ secreting cells (SC) that were not
specific for PCV2 were detected by ELISPOT assay at day 7 p.i. Interestingly, this response was
absent in the PCV2/PPV dual infected animals. PCV2-specific IFN-γ SC were observed in the PCV2/
PPV infected group at 7 d p.i. and in the PCV2 single infected group at 21 d p.i. A reduction in the
numbers of IFN-γ SC was observed following anti-CD4 and anti-CD8 antibody treatment,
suggesting roles for both CD4+ and CD8+ T cells in the response against PCV2 infection. This was
supported by an observed increase in the percentage of IFN-γ positive CD8hi cytotoxic T cells as
well as IFN-γ positive CD8-/low helper T cells after PCV2 in vitro re-stimulation.
Conclusions: Infection of weaned SPF piglets with PCV2 alone or combined with PPV does not
induce disease and in both cases a relatively slow anti-PCV2 antibody response and weak T
lymphocyte responses were found. Knowledge on such immunological characteristics is important
for both PCV2 pathogenesis and vaccination.
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Background
Porcine circovirus type 2 (PCV2) is a non-enveloped, cir-
cular single stranded DNA virus belonging to the Circov-
iridiae virus family [1], and is the causative agent of a
number of diseases in swine, particularly postweaning
multisystemic wasting syndrome (PMWS) [2]. The
genome of PCV2 is 1759 nucleotides long, making it one
of the smallest viruses replicating autonomously in mam-
malian cells [3]. PCV2 was first isolated from tissues of
PMWS diseased pigs in Canada [4], the US and Europe [5]
in 1998. Disease has been reproduced by viral co-infec-
tion of colostrum-deprived or gnotobiotic piglets with
PCV2 and porcine parvovirus (PPV) [6,7]. Particular vac-
cine adjuvant administration has also been shown to
assist development of PMWS disease after experimental
PCV2 infection [8,9]. Nevertheless, PCV2 is clearly the pri-
mary causative agent of PMWS [10], requiring the second-
ary factors such as co-infections or vaccinations for full
expression of the disease. It is assumed that secondary
viral infections or the administration of immunostimula-
tory compounds activate PCV2 infected cells to divide [9],
thus promoting the replicative cycle of PCV2, which is
dependent on the host DNA polymerase [11].
Nevertheless, neither natural nor experimental PCV2
infection together with cofactors will induce disease in all
infected animals. On the farm, PCV2-induced diseases
have been found to increase the pig mortality rate from 2-
3% to 14-30%. PMWS-diseased animals are most often in
the age range of 8-12 weeks old. They display clinical
symptoms of wasting, diarrhoea, jaundice, respiratory dis-
tress and enlarged lymph nodes [12]. Typical histological
findings are also reported in lymph nodes: The follicular
architecture is lost, lymphocytes are depleted, histiocytes
and multinucleated giant cells infiltrate the lymph nodes,
and basophilic inclusion bodies are detected in the histi-
ocytes [13]. In addition, interstitial pneumonia, mononu-
clear inflammatory infiltration in the liver,
lymphoplasmacytic colitis and peri-endarteritis are
observed [14,15].
The induction of anti-PCV2 neutralizing antibodies (Ab)
was shown to correlate with protection from disease [16].
While important, Ab are effective at targeting extracellular
virus and cell surface antigen (Ag) only. PCV2 has been
shown to infect epithelial, endothelial and monocytic
cells in vivo [14,15,17,18], and in vitro observations on pri-
mary cells have confirmed that this reflects replicating
virus [19-22]. Considering that PCV2 is a non-enveloped
virus, its capsid protein is unlikely to be expressed at the
surface of infected cells; indeed, there is no evidence that
this occurs. Accordingly, virion proteins could not repre-
sent a target for Ab-mediated immune defence against
PCV2-infected cells; other cytotoxic mechanisms would
be required. While natural killer cells and the cytotoxic T
lymphocyte (CTLs)-based immune defences are strong
candidates for eradicating PCV2-infected cells, there have
been no studies characterizing the existence of PCV2-spe-
cific T cell responses - neither CTLs nor T helper (Th) cell
responses. Such immune parameters are particularly
important for asymptomatic animals, and therefore for
our understanding of immune defences in animals resist-
ing disease development.
One study of the immune compartments influenced by
PCV2 infection demonstrated a lymphopenia involving
naïve CD4+CD8- Th cells, memory/effector CD4+CD8+ Th
cells and CD4-CD8+ CTLs in diseased, but not healthy ani-
mals [23]. Interleukin 10 (IL-10) and interferon gamma
(IFN-γ) have also been noted following in vitro PCV2 re-
stimulation [24], suggesting the existence of both regula-
tory and stimulatory/effector pathways. In contrast, there
has been no study elaborating on the development of T
lymphocyte responses in asymptomatic, PCV2-infected
animals. Therefore, the present study was conducted to
analyse and characterise the PCV2-specific T cell responses
developing during experimental PCV2 and PCV2/PPV
dual infection in asymptomatic animals.
Results
Clinical monitoring and daily weight gain
Following intranasal infection of the 3-week old SPF pig-
lets with PCV2, PPV or PCV2/PPV, as described in Materi-
als and Methods, enlarged inguinal and popliteal lymph
nodes were noted in the PPV single and PCV2/PPV dual
infected animals from day 10 to day 17 p.i. This was taken
to indicate the presence of the PPV infection. None of the
animals in any group displayed fever during the 35 days
of experiment (Fig. 1A); a slight decrease in temperature
was noted for the PCV2 single, PPV single and PCV2/PPV
dual infected animals compared with the PBS group until
day 13 p.i. (Fig. 1A). This was considered to be influenced
by differences in food management until day 13 p.i.,
because the PBS control animals had remained in the SPF
breeding unit while the infected animals were in the con-
tainment facility. The ad libitum food management can
also explain the higher average daily weight gain in the
PBS group (Fig. 1B). Overall, the average daily weight gain
did not significantly differ among the PCV2/PPV dual,
PCV2 single and PPV single infected animal groups (Fig.
1B).
PPV specific antibodies are present from day 10 p.i. in the 
PPV infected animals
The presence of anti-PPV Ab was analysed by a commercial
competitive Ab ELISA. At day 10 p.i., all PCV2/PPV dual
and PPV single infected animals had seroconverted against
PPV (Fig. 2A). The percentage inhibition (PI) values
reached 84% and 89% respectively (Fig. 2A), increasing to
94% and 95% at day 21 p.i., and remaining at these levelsBMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
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during the remainder of the observation period of 35 days
(Fig. 2A). While the animals of the PBS group were always
negative for anti-PPV Ab, the animals of the PCV2 single
infected group seroconverted at day 28 p.i. against PPV (Fig.
2A). This may be explained by the fact that the PCV2 single
infected animals were handled by the same persons in the
same building as the PPV infected animals, even though the
animals were in separate rooms with separate ventilation;
in contrast, the PBS control group was housed and handled
separately in an SPF unit. The PPV contamination of the
PCV2 single infected group happened at around day 10-14
p.i. Therefore, this group was excluded from all statistical
comparisons after day 10 p.i.
Analysis of anti-PCV2 antibodies and PCV2 viraemia
When assayed for anti-PCV2 specific IgG, the PBS control
group values were always below background level. The
plasma samples from the PPV single infected animals also
remained below background levels. Seroconversion
against PCV2 was clearly observed at day 24 p.i. in the
PCV2/PPV dual infected group, and 4 days later in the
PCV2 single infected group (Fig.2B). At day 28 p.i., all of
the PCV2 infected animals had seroconverted against
PCV2; the Ab titres increased to comparable levels at day
35 p.i. in both groups (Fig. 2B).
The presence of PCV2 DNA in the piglet plasma was ana-
lysed by TaqMan real time PCR to seek any evidence of
PCV2 viraemia. Samples from the PBS control and the
PPV single infected animals all tested negative for the
presence of PCV2 DNA (data not shown). In contrast,
PCV2 DNA was detected in plasma samples from four of
the PCV2 single and all five of the PCV2/PPV dual infected
animals at day 7 p.i. (average Ct value +/- SD of 38.9 +/- 5
and of 38.6 +/- 3.5 respectively). Interestingly, this appar-
ent viraemia was transient; all other time points tested
gave negative results (data not shown).
Further analysis of PCV2 viraemia was attempted in terms
of the presence of viral antigen in PBMC. Intracellular
staining for the viral Capsid (Cap) protein by flow cytom-
etry failed to detect antigen, neither in CD172a(SWC3)+
monocytes nor in CD4+ lymphocytes (data not shown).
PCV2/PPV dual infected animals display a transient 
decrease in leukocyte and lymphocyte counts
The total leukocytes were counted for individual animals
in each group, and the group values compared statisti-
cally. A significant decrease in the leukocyte levels was
detected in the PCV2 single and PCV2/PPV dual infected
groups between days 7 and 10 p.i. (43 and 46 × 106 cells/
ml respectively) compared with the PBS controls (data not
shown). Interestingly, the PPV group showed the highest
levels of leukocytes at this time (79 × 106cell/ml) (data
not shown).
In order to analyse the leukocytes in more detail, and to
relate to previous publications, the B- and T-lymphocyte
numbers were determined by staining for surface IgG and
CD3a. Consistent with the observed decrease in the leuko-
cyte numbers, the B cell counts in the PCV2/PPV dual
infected group declined significantly to all other groups at
7 d p.i. (Fig 3A). However, this was not observed with the
PCV2 single infected group. Interestingly, a comparable
significant rise in B cell levels was noted, in the PCV2/PPV
dual and PPV single infected groups, at day 14 p.i., com-
pared to the PBS group. (Fig. 3A). The significantly higher
B cell numbers persisted in the PPV single infected group
until day 35, compared to the PBS group. The B cell
number in the PCV2/PPV dual infected animals was sig-
nificantly lower than the B cell number in the PPV and
PBS group at day 35 p.i. (Fig. 3A).
Body temperature and average daily weight gain of animals  infected with PCV2 and/or PPV Figure 1
Body temperature and average daily weight gain of 
animals infected with PCV2 and/or PPV. (A) Body tem-
perature. The rectal body temperature was measured for all 
animals at daily intervals. Mean values of the groups are 
shown. (B) Weight gain. The average daily weight gain (kg) is 
shown for each animals within a group (filled and open sym-
bols); group mean values are represented by the bar symbol.BMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
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A significant decrease was also observed for the T lym-
phocytes at day 7 p.i. in the PCV2/PPV dual infected
group, but not in the other groups (Fig. 3B). While an
increase was noted in this group at day 14 p.i., this was
statistically significant from the PBS control group only
for the PPV single infected group (Fig. 3B). Again similar
to the B cell counts, the T cell numbers significantly
decreased at day 35 p.i. in the PCV2/PPV dual infected
animals compared to the PPV single infected group or PBS
group (Fig. 3B).
Overall, the data shows a decrease in leukocyte and lym-
phocyte numbers in the PCV2/PPV dual infected animals,
even though the animals remained clinically asympto-
matic. Although there was a "recovery" of the leukocyte
numbers thereafter, this did not continue to increase with
the PCV2/PPV dual infected animals in the same fashion
as in the PBS control group and PPV infected group. This
was particularly the case for the T lymphocytes.
PBMC of PCV2 infected animals respond to PCV2 re-
stimulation by IFN-γ secretion
IFN-γ ELISPOT assay for ex-vivo PCV2 re-stimulation of
PBMC was employed to quantify the PCV2 specific IFN-
γSC arising following infection. Firstly, PBMC were freshly
isolated from two PCV2 immune adult pigs, to determine
the levels and range of IFN-γSC which could be expected.
The cells were re-stimulated with increasing amounts of
PCV2 or mock for 24 h. A clear PCV2-specific response
was observed in terms of the numbers of IFN-γSC/106
cells; this increased in a dose-dependent manner when the
re-stimulation employed PCV2 (Fig. 4A).
The above permitted an analysis of the time-dependent
appearance of PCV2-specific IFN-γSC following PCV2
infection, using freshly isolated PBMC from the PBS con-
trol, PCV2 single, PPV single or PCV2/PPV dual infected
piglets. The number of IFN-γ SC/106  cells at day 0
remained at background levels for all groups (Fig. 4B). In
three of the five PCV2/PPV dual infected animals, PCV2
specific IFN-γ SC were detected at day 7 p.i. (Fig. 4C). This
was clearly PCV2 specific, because re-stimulation with
mock did not lead to IFN-γ secretion. In contrast, the
number of IFN-γ SC in the PCV2 single infected animals
was similar to the background levels obtained with mock
antigen stimulation. By day 21 p.i., PBMC from both
PCV2/PPV dual and PCV2 single infected groups gave a
PCV2-specific IFN-γ SC response upon in vitro re-stimula-
tion (Fig. 4D). In both groups, four out of five animals
responded to the virus re-stimulation, giving IFN-γ SC
numbers similar to or slightly higher than the numbers
obtained for the PBMC from the PCV2/PPV dual infected
group at day 7 p.i.
An interesting result was observed with the PBMC from
the PPV single-infected group. At day 7 p.i., the level of
IFN-γ SC raised in the PPV single infected group regardless
if cells were restimulated with PCV2 or mock antigens
Anti-PPV and anti-PCV2 Ab titres Figure 2
Anti-PPV and anti-PCV2 Ab titres. (A) Anti-PPV specific antibodies were measured with a commercial competitive Ab 
ELISA, at time points (days p.i.) indicated on the x-axis. The values are given as percent inhibition (PI), calculated as described 
in Materials and Methods. Means of the groups, +/- SD, are shown.(B) Anti-PCV2 IgG Ab titres were measured by an indirect 
ELISA. The log10 of the reciprocal end-point dilution is given for the time points (days p.i.) indicated on the x-axis. Mean values 
for the groups are shown by the histograms, +/- standard deviation (SD).BMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
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B- and T-lymphocyte counts Figure 3
B- and T-lymphocyte counts. (A) B lymphocyte counts. PBMC were isolated at the time points (days post-infection (p.i.)) 
indicated on the x-axis, and stained with anti-IgG H+L Ab to analyse the B cell numbers. The absolute B cell counts were calcu-
lated and expressed as ×103 cells/ml. Individual animals are represented by the open and filled symbols, with the mean values 
for the groups shown by the continuous line. (B) T lymphocyte counts. The above PBMC were stained for CD3a expression, 
to analyse the T lymphocyte counts. These counts are given as × 103 cells/ml for the individual animals (open and filled sym-
bols), with the group mean values shown as the continuous line. *P < 0.05.BMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
Page 6 of 13
(page number not for citation purposes)
(Fig. 4C). Although this observed response was the high-
est for all the groups, it was not PCV2-specific. Moreover,
the level of activation did not relate to that obtained with
cells from the PCV2/PPV dual infected group (Fig. 4C)
and the response against the mock antigen was not
observed when the animal donors of the PBMC had been
dually infected with PCV2 and PPV (Fig. 4C). These results
suggested that an unspecific IFN-γ response is elicited in
PBMC from the PPV single infected animals and is absent
in the PCV2/PPV animals, which only display an anti-
PCV2 specific response.
By day 21 p.i., PBMC from the PPV single-infected group
were still capable of responding similarly to both PCV2
and mock antigens, but now the response was lower than
that observed at day 7 p.i. (Fig. 4D). Moreover, the IFN-γ
SC response was lower than the PCV2-specific response
obtained with PBMC from the PCV2 infected groups (sin-
gle and dual) stimulated with PCV2 (Fig. 4D).
Overall, it can be seen that the PCV2/PPV dual and the
PCV2 single infected groups did generate PCV2-specific
lymphocytes, in terms of IFN-γ SC. These were clearly
identifiable at 7 and 21 days p.i., respectively. There was
IFN-γ secreting cells after ex vivo PCV2 re-stimulation Figure 4
IFN-γ secreting cells after ex vivo PCV2 re-stimulation. (A) PBMC from two adult PCV2-immune animals were used as 
positive controls to evaluate the ability of the test to detect PCV2 specific IFN-γSC. The PBMC were re-stimulated for 24 h 
with PCV2-infected cell lysate, or mock cell lysate as negative control, at increasing MOI based on the titre of the PCV2 
(TCID50/cell, x-axis). The IFN-γSC were measured by ELISPOT assay as described in Materials and Methods, and expressed per 
106 cells. (B-D) PBMC were isolated from the piglets which had received PBS (control), PCV2 single infection, PCV2/PPV dou-
ble infection and PPV single infection. The cells were re-stimulated with PCV2 or mock antigen at 1 TCID50/cell (or equivalents 
dilution for the mock) for 24 h, and the IFN-γSC detected by ELISPOT assay. The mean values of the groups, +/- SD, are shown 
for PBMC isolated before infection (0 days) (B), 7 d p.i. (C) and 21 d p.i. (D). The IFN-γSC are calculated per 106 cells.BMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
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variation in the number of IFN-γ SC/106  cells, both
between the groups and between animals, ranging from 4-
16 IFN-γ SC/106 cells between individual piglets respond-
ing in a positive and PCV2-specific manner.
Contribution of CD4+ and CD8+ cells in the PCV2-specific 
recall response
In order to characterize the nature of the IFN-γ SC detected
by the above ex vivo analyses, the recall response of frozen
PBMC samples from the PCV2-immune piglets was ana-
lysed in the presence of anti-CD4 and anti-CD8 Ab [25].
The thawed PBMC were expanded for 5 days in the pres-
ence of the virus plus 50 U/ml of rpoIL-2, to expand anti-
gen-specific T-cells expressing higher levels of CD25 (IL-2
receptor α chain) than unspecific naive cells [26]. An ini-
tial experiment was performed to ascertain if PBMC which
had been frozen would retain their capacity to respond
against the PCV2 antigen. Fig. 5 shows that the frozen
PBMC efficiently responded to the PCV2 re-stimulation in
terms of IFN-γ SC, albeit with a lower frequency of IFN-γ
SC compared with freshly isolated cells. Moreover, the
detection sensitivity for the IFN-γ SC assay was increased
when the re-stimulated PBMC were cultured for 5 days.
When the in vitro PCV2 re-stimulation assays were
repeated in the presence of anti-CD4 or anti-CD8 Ab,
both treatments impaired the development of the IFN-γ
SC (Fig. 6A). In contrast, anti-CD1 Ab did not decrease the
number of IFN-γ SC induced by the PCV2 re-stimulation
(Fig. 6A).
Considering the results obtained with anti-CD4 and anti-
CD8 Ab in the ELISPOT assay, the PBMC from PCV2-
immune animals, isolated 3 months after infection, were
analysed further with respect to their phenotype by flow
cytometry. Following in vitro re-stimulation, the IFN-γ SC
were defined in terms of CD8 expression, and the pres-
ence of intracellular IFN-γ (Fig. 6B, C). MHC class I
restricted CTLs were defined by gating on the CD8hi pop-
ulation and the remaining lymphocytes by gating on the
CD8-/low cells. The later were composed of Th, NK cells, γ/
δ T cells and B cells. Both CD8hi CTLs and CD8-/low cells
were found to express the IFN-γ in response to PCV2 anti-
gen (Fig. 6B). The IFN-γ expressing cells were clearly
found to be reactive lymphocytes, represented by an
increase in IFN-γ positive cells if the gate of interest was
placed on blasting cells (Fig. 6C). The observation that
cells isolated from naïve pigs showed no IFN-γ response
following restimulation with PCV2 (data not shown)
would imply that the observed IFN-γ production within
the CD8-/low cell population represented a Th cell-derived
memory response. Together with the observed impair-
ment of the PCV2-specific IFN-γ response by both anti-
CD4 and anti-CD8 Ab (Fig. 6A) we conclude that PCV2-
specific T lymphocytes reside within both CTL and Th
populations, at least with respect to the IFN-γ response.
Discussion
Although PCV2 will cause the development of diseases
such as PMWS, not all PCV2-infected animals develop dis-
ease symptoms [10,27]; in fact the majority may remain
asymptomatic. Moreover, a number of models, including
the PCV2/PPV co-infection model in SPF piglets used for
the present work, generate more often asymptomatic
infections [28]. In view of the reports showing that PCV2
infection leads to modulation of T lymphocyte activity
[23,24,29], the present work sought to characterize the T
lymphocyte response in animals following infection with
PCV2. This is particularly pertinent considering the
reports on T lymphocytes in sow colostrum [30-32], and
the reported transfer of antigen-specific T-cell immunity
to piglets, either by transplacental passage or via the colos-
trum [30]. The study was designed to relate observations
on the T lymphocyte subsets to the development of spe-
cific anti-PCV2 humoral immunity, since the presence of
PCV2 specific neutralizing antibodies argues for the exist-
ence of PCV2 specific Th cells [16].
Accordingly, samples were employed from an experimen-
tal infection by PCV2 alone or in combination with PPV,
in which the virus-inoculated animals remained asympto-
Comparison of the PCV2 re-stimulation profile for freshly  isolated compared to frozen and then in vitro expanded  PBMC Figure 5
Comparison of the PCV2 re-stimulation profile for 
freshly isolated compared to frozen and then in vitro 
expanded PBMC. PBMC were re-stimulated with PCV2, 
mock antigen, or medium alone directly after isolation 
("PBMC fresh; 24 h"). Aliquots of the PBMC were frozen 
under liquid nitrogen, before thawing and expanding by cul-
ture in the presence of rpoIL-2 together with PCV2, mock 
antigen, or medium alone. This expansion was for 24 h 
("PBMC thawed; 24 h"), 3 days ("PBMC thawed; 3 days") or 5 
days ("PBMC thawed; 5 days") prior to analysis for IFN-γ SC 
by the ELISPOT assay. Means of triplicates +/- SD of two 
experiments are shown.BMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
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matic. The asymptomatic outcome of PCV2/PPV dual
infection in colostrum-fed piglets was also reported by
other groups [10,28]. The exact reason that certain ani-
mals remain subclinically infected is not known but
reflects the field scenario. The genetic background of the
animals, environmental factors like stress and manage-
ment factors like food change and bad hygiene have a cer-
tain impact on disease development [12]. Recently,
certain PCV2 viral strains were correlated to different dis-
ease outcome [33,34]. Therefore, multiple reasons may
have caused the failure of disease reproduction in this
study. In general, the absence of clinical disease correlates
with the presence of a PCV2 specific B and T cell response
in the infected animals.
The experimental data from the present work is in agree-
ment with published data on humoral immune defence
development [28], in that the development of subclinical
PCV2 infection was confirmed by the presence of PCV2-
specific antibodies and PCV2 DNA in the blood. Interest-
ingly, the PCV2 viraemia in this study was transient
reflecting the ongoing PCV2 specific T and B cell immune
response in the infected animals and clearance of the cir-
culating virus. The pre-existence of PCV2 maternal anti-
bodies can be ruled out, as the piglets tested at the age of
3 weeks and the mother sows displayed no PCV2 specific
antibodies.
No differences in the levels of the PCV2 Ab titres were
observed in the PCV2/PPV dual infected animals com-
pared to the PCV2 single infected animals. When com-
pared with the kinetics of the anti-PPV response, the
development of the anti-PCV2 Ab appeared to be delayed,
an observation also made by others [28]. This may reflect
Characterization of anti-PCV2 specific T lymphocytes Figure 6
Characterization of anti-PCV2 specific T lymphocytes. (A) Anti-CD4 and -CD8 mAbs reduce IFN-γ SC. PBMC from 
PCV2-immune animals were treated with mAbs against the CD4 and CD8 T cell receptors, or anti-CD1 as control for 1 h 
prior to PCV2 or mock antigen re-stimulation for 5 days (as in Fig. 5). The IFN-γ SC were measured by ELISPOT assay, and cal-
culated per 106 cells. Mean values of triplicates of one representative experiment +/- SD are shown. (B and C) IFN-γ SC 
detected by flow cytometry. PBMC from PCV2-infected piglets (3 months after infection) were re-stimulated with PCV2 or 
mock antigen for 5 days prior to staining for the presence of intracellular IFN-γ. The cells were also labelled for the surface 
markers CD8 to differentiate MHC class I restricted CTLs as CD8hi cells from Th cells located within the CD8-/lo cell popula-
tion. The latter includes also NK cells and γ/δ T cells. Values shown on the y-axis represent the percentage of IFN-γ positive 
cells. The symbols represent the individual animals. In C the percentage of the IFN-γ positive cells within the blasting cells 
defined by gating on cells with high forward scatter is shown. For B and C, monocytic cells were excluded based on their 
CD172a expression.BMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
Page 9 of 13
(page number not for citation purposes)
differences in the immunogenicity of the two viruses [35-
38], but may also relate to the rate at which PCV2 repli-
cates [21]. The response in the PCV2/PPV dual infected
animals did precede that in the PCV2 single infected ani-
mals by 4 days. Although one could argue that the con-
comitant PPV infection may have activated the immune
system to respond more rapidly against PCV2, further
experimentation would be required to ascertain if such a
short time delay has any significance. On the other hand,
one has to consider the PPV infection that occurred acci-
dentally at around day 10-14 p.i. in the PCV2 single
infected animals and might have influenced the PCV2
specific Ab response of this group at later time points. Not
to cause misinterpretation of the data, the PCV2 single
infected group was only included in the statistical com-
parisons until day 10 p.i.
Considering the PCV2 infection, no apparent influence
on the humoral response against PPV was observed: The
titres and kinetics of the anti-PPV Ab response did not dif-
fer between the PPV single and PCV2/PPV dual infected
groups.
A full appreciation of adaptive immune defences develop-
ing after PCV2 infection requires analysis of T lymphocyte
activity, particularly when considering the influence of
PCV2 on T lymphocyte numbers and activities [23,24,29].
The present work identified an influence on lymphocytes
in asymptomatic animals, seen as a decrease in CD3+ T
cells and IgG+ B cells in PCV2/PPV dual infected animals
(relating to the published observations with symptomatic
animals [23,24,29]). Being a transient decrease, followed
by a significant rise in B and T cell numbers, the animals
may recover from an immunosuppressed state caused by
the concomitant PCV2/PPV infection. This recovery
would explain the asymptomatic outcome.
Using ELISPOT with PBMC from PCV2-infected animals,
we were able to estimate the development of the fre-
quency of PCV2-specific T-cells. These were detected at an
earlier time point (7 d p.i.) in the PCV2/PPV dual infected
animals than in the PCV2 single infected animals. All
PCV2-infected animals responded to PCV2 recall antigen
stimulation with IFN-γ secretion by 21 days post-infec-
tion. This kinetics is slower in comparison to that reported
for experimental infection of gnotobiotic pigs with
human norovirus [39] - peaking at day 7 p.i., followed by
a relative stability. Porcine reproductive and respiratory
syndrome virus (PRRSV) also induces IFN-γ SC with a
similar kinetics [40], the PRRSV-induced activity peaking
at day 14 p.i., after which the numbers were relatively sta-
ble for the remainder of the experiment. Our data suggest
that PCV2 is not a strong a T cell immunogen probably
due to a slow replication of PCV2; the PCV2-specific
humoral response is also slow to develop. Either of these
scenarios would be in agreement with our previous dem-
onstration that PCV2 alone does not activate professional
antigen presenting cells or lymphocytes in vitro [19], and
is seen to replicate slowly in primary cell cultures [21].
Early after infection, an unspecific IFN-γ response was
observed in the PPV single infected animals: Similar levels
of IFN-γ SC were induced by in vitro re-stimulation with
the negative mock control antigen and PCV2 antigen. This
response appears to be antigen-unspecific, possibly
reflecting NK cells or γ/δ T cell activities. Interestingly, it
was absent in the PCV2/PPV dual infected animals, indi-
cating a possible immunomodulatory effect associated
with the PCV2 infection. This relates to a recent publica-
tion showing that in vitro PCV2-infected PBMC displayed
an impaired IFN-γ response upon recall stimulation with
pseudorabies virus [29]. The reported effect was appar-
ently mediated by IL-10, which can influence antigen-spe-
cific and antigen non-specific responses, as mediated by
NK cells and γ/δ T cells.
The anti-PCV2 T lymphocyte response was further charac-
terized using blocking antibodies which would interfere
with functional CD4 and CD8 molecules. Analyses
showed that the response involved both CD4+ helper and
CD8+ cytotoxic T cells in the IFN-γ response. This was sup-
ported by an increase in IFN-γ secreting CD8hi and CD8-/
low cells when PBMC from PCV2 infected animals were re-
stimulated with PCV2 in vitro. Future studies are required
to determine how such responses develop in animals with
PCV2 associated diseases and after vaccination, and how
they contribute to protective immunity.
Conclusions
Asymptomatic PCV2-infected animals develop antigen-
specific humoral and T cell responses, albeit with a rela-
tively slow kinetics. The latter involves both CTL and
helper T lymphocyte populations, confirmed as PCV2-
specific through comparative stimulations with PCV2 and
mock antigens.
Methods
Virus
Porcine circovirus type 2 (PCV2) pool 1452/3 and porcine
parvovirus (PPV) pool 1005 were kindly provided by
Francis McNeilly, QUB, Belfast. Virus titres were deter-
mined on the PCV2/PCV1-negative porcine PK15-A kid-
ney cell line (also kindly provided by Francis McNeilly).
Titres of 104.75  50% tissue culture infectivity dose
(TCID50)/ml and 106.0 TCID50/0.5 ml were determined
for the PCV2 and the PPV inocula respectively. In the
ELISPOT assay, a lysate from PK15-A cells infected with
the PCV2 strain Stoon 1010 [4] (also kindly provided by
Francis McNeilly) was used.BMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
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Experimental infection and clinical monitoring
The animal experiment was approved by the state com-
mittee for animal experimentation (authorization N° 18/
04 delivered by the canton Bern) and carried out in
accordance with the laws on care and use of laboratory
animals in Switzerland.
Twenty 3-week old SPF piglets were randomly divided
into four groups that were kept apart in separate isolated
rooms of the institute BSL4 containment facility. The pig-
lets received PCV2 (group 1), PPV (group 2), PCV2 + PPV
(group 3), or Dulbecco's phosphate buffered saline (Inv-
itrogen) (PBS) (group 4), administered intranasally on
three consecutive days. At day 0, the piglets of the groups
1 and 3 were infected with PCV2 at a titre of 104.65 TCID50/
animal; piglets of groups 2 and 3 were infected with PPV
at a titre of 106.2 TCID50/animal. The piglets of the PBS
control group (group 4) received corresponding volumes
of PBS. On day 1 and 2 post infection (p.i.), additional
doses of PCV2 and PPV were applied, at titres correspond-
ing to 104.35  TCID50/animal and 105.9  TCID50/animal
respectively. Body temperature and clinical symptoms
were recorded daily, and the body weight every second to
third day.
Blood sampling
Blood was collected at day 0, 7 days (d), 10 d, 14 d, 17 d,
21 d, 24 d, 28 d and 35 d p.i., and diluted in Alsever's anti-
coagulant solution. By whole blood staining with Tuerk's
solution (Dr. Grogg Chemie Ag, Bern, Switzerland), the
total leukocyte number was calculated. Plasma samples
were collected after a centrifugation step at 1,000 × g for
25 min and stored at -70°C. Peripheral blood mononu-
clear cells (PBMC) were isolated from the buffy coat frac-
tion of blood by density centrifugation over Ficoll-Paque
(1.077 g/liter) as described previously [41]. For long-term
storage under liquid nitrogen, the PBMC were resus-
pended in Dulbecco's Modified Eagle's Medium (DMEM)
containing 50% (v/v) FBS (all from Invitrogen) and 10%
(v/v) DMSO.
Anti-PPV and anti-PCV2 antibody ELISAs
Anti-PPV antibodies (Ab) were detected using a PPV com-
petitive antibody ELISA kit Svanovir (10-7400-02;
Svanova Biotech, Uppsala, Sweden). The percent inhibi-
tion (PI) values were calculated with the given formula: PI
= 100-(MEAN OD samples/MEAN OD negative control),
where OD = optical density as 450 nm. Positive plasma
samples showed a PI value greater than 50 and samples
exceeding a PI value of 80 were considered as strongly
positive.
Anti-PCV2 specific Ab were detected with an indirect anti-
PCV2 Ab ELISA, established in our laboratory. Briefly,
Nunc MaxiSorb™ plates were coated with 1 μg/ml of PCV2
ORF2 virus-like particles (VLPs) (kindly provided by Dr.
C. Andreoni, Immunology, Discovery Research, Merial,
Lyon, France) in 100 μl PBS overnight (O/N). The plates
were blocked with PBS/1% (w/v) dried skimmed milk for
1 h at 37°C, and washed once with PBS/0.05%(v/v)
Tween-20 (washing buffer). The plasma samples were
added in dilutions from 1:50 to 1:800 in PBS/1% (w/v)
bovine serum albumin (BSA, bovuminar cohn fraction V,
Intergen Company Serologicals) for 1 hour (h) at room
temperature (RT). The plates were washed five times and
horseradish peroxidase-conjugated polyclonal anti-swine
IgG F(ab')2  fragments (Jackson ImmunoResearch),
diluted in PBS, 0.05% (v/v) Tween-20, 1% (w/v) dried
skimmed milk, 1% (v/v) rabbit serum (Sigma) was added.
After 1 h incubation at 37°C and five washing steps, the
substrate O-Phenylenediamine (OPD) (Sigma: P-8787)
plus 0.0001% (v/v) H2O2 was added for 40 minutes, and
the absorbance measured at 450 nm. Samples were con-
sidered as positive if the optical density (OD450 nm) values
equalled or exceeded 0.1 at dilutions higher than 1:100.
Samples from animals treated with PBS were always
below OD450 nm 0.1.
Restimulation of PCV2 specific cells
For ex vivo IFN-γ ELISPOT assays, freshly isolated PBMC
were resuspended in DMEM, 10% (v/v) FBS, 1× Penicil-
lin/Streptomycin, 20 μM 2-mercaptoethanol (2-ME) (all
from Invitrogen). 200 μl of 2.5 × 106 PBMC/ml were
seeded in 96-well multiscreen plates, and the cells restim-
ulated with PCV2 virus lysate of the strain Stoon 1010 [4]
or with mock lysate, diluted to give an MOI of 1 TCID50/
cell (or equivalent dilution for the mock) for 24 h.
Thawed PBMCs were also employed for the IFN-γ ELIS-
POT. They were seeded at a concentration of 3 × 106 cells/
ml in 24 well plates, and restimulated with PCV2 lysate or
mock lysate at an MOI of 0.1 TCID50/cell (or equivalent
dilution) for 5 days. The cells were harvested, counted,
and stained for flow cytometry analysis or re-plated on 96-
well mutliscreen plates at a concentration of 1.25 ×
106cells/ml for IFN-γ ELISPOT analysis. When indicated
in the results, 50 U/ml of the recombinant porcine
cytokine IL-2 (R&D systems) were added to the cultures.
In order to block the CD4 or CD8 dependent IFN-γ secre-
tion, 50 μl of anti-CD4 Ab (74-12-4), anti-CD8 Ab (11/
295/33), or control anti-CD1 Ab (76-7-4) were incubated
with the cells for 1 h at 37°C, prior to PCV2 restimulation
[25].
IFN-γ ELISPOT assay
The ELISPOT was performed with minor modifications as
described previously [42]. Briefly, 96-well multiscreen
plates (Millipore MAIPS4510) were coated with 0.5 μg/ml
of mouse anti-porcine IFN-γ mAb (P2G10, BD bioscience,BMC Veterinary Research 2009, 5:45 http://www.biomedcentral.com/1746-6148/5/45
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Allschwil, Switzerland) diluted in PBS at 4°C O/N. The
plates were washed twice with 200 μl of cold DMEM, 10%
(v/v) FBS and blocked for 2 h at 37°C. PBMC were seeded
at the above mentioned concentrations into the plates,
and incubated at 39°C. Reference positive control cells
were activated with 10 μg/ml of the mitogen ConA (Amer-
sham Pharma Biotech, Uppsala, Sweden). After 24 h, the
medium was aspirated and the cells lysed by addition of
cold distilled water for 5 minutes. After washing three
times with PBS, 0.5% (v/v) Tween-20 (washing buffer),
the plates were incubated with 0.17 μg/ml biotinylated
anti-porcine IFN-γ Ab (P2C11, BD Biosciences, Allschwil,
Switzerland) in PBS at 4°C O/N. The plates were washed
five times in washing buffer, and incubated with Streptav-
din HRP (DakoCyomation, Dako AG, Baar, Switzerland)
diluted in PBS 1 h at 37°C. After an additional washing
step, the plates were revealed with SIGMAFAST™
3,3'Diaminobenzidine tablets (Sigma, Buchs, Switzer-
land) dissolved in distilled water. After 20 min incubation
at RT in the dark and drying of the plates, the number of
spots was determined with a computer-assisted video
image analyzer (ELISPOT reader, AID, GmbH, Strassberg,
Germany).
Antibodies
For phenotyping of cells, the following Ab were used: flu-
orescein (FITC) conjugated goat anti swine IgG
(H+L)(Jackson ImmunoResearch, Milan Analytica,
Magden, Switzerland); mouse anti-swine CD8 beta chain
(PG164A, Veterinary Medical Research & Development,
Inc., Pullman, WA); mouse anti-swine IFN gamma (IFN-
γ) (P2G10 BD biosciences, Allschwil, Switzerland); anti-
swine workshop cluster 3a (SWC3a; 74-12-15A); mouse
anti-swine CD8 (11/295/33); mouse anti-swine CD3a
(PTT3/FyH2). The latter three monoclonal Ab (mAb)
were produced from hybridomas kindly provided by Dr.
Armin Saalmüller, University of Veterinary Medicine,
Vienna, Austria. Anti-Capsid protein ORF2 mAb 7G5-G4-
A1 (IgG2a) was kindly provided by Dr. Allan Gordon
QUB, Belfast.
Flow cytometry
The PBMC were stained with anti-CD3a and anti-IgG
(H+L) Ab to analyse the relative levels of T- and B-lym-
phocytes respectively. The absolute numbers of lym-
phocytes were calculated relative to the total leukocyte
numbers. The PBMC were stained with anti-SWC3a, anti-
CD4 and after a fixation and permeabilisation step (Fix
and Perm kit, ADG An Der Grub, Bio research GMBH,
Austria) with anti-Capsid Ab to analyse the presence of
Capsid antigen in the monocytic cells.
For intracellular IFN-γ detection, PCV2 re-stimulated
PBMC were treated with 2 μg/ml of Brefeldin A (Sigma,
Buchs, Switzerland) 4 h prior to staining with anti-
SWC3a, anti-CD8 and anti-IFN-γ Ab. The cells were fixed
and permeabilised with the Fix and Perm kit (ADG An Der
Grub, Bio research GMBH, Austria) before staining for the
intracellular cytokine IFN-γ. Antibodies were detected by
fluorescein, phycoerythrin or biotin-conjugated goat
F(ab')2  anti-mouse isotype specific immunoglobulins
(Southern Biotechnology Associates, Bioconcept, Switzer-
land). Streptavidin RPE-Cy5 (DakoCyomation, Dako AG,
Baar, Switzerland) was used to develop the biotinylated
conjugates.
Statistical analysis
The statistical significance of the differences between
groups was analysed with SigmaStat version 3.0, employ-
ing ANOVA on ranks and t-tests. The PCV2 single infected
group was included in the statistical analysis until 10 d p.i.
but excluded from the analysis of later time points due to
PPV contamination.
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